θ-Defensins Prevent HIV-1 Env-mediated Fusion by Binding gp41 and Blocking 6-Helix Bundle Formation

This publication has 46 references indexed in Scilit:

• Conformational Changes in HIV-1 gp41 in the Course of HIV-1 Envelope Glycoprotein-Mediated Fusion and Inactivation
  Biochemistry, 2005
• RC-101, a Retrocyclin-1 Analogue with Enhanced Activity against Primary HIV Type 1 Isolates
  AIDS Research and Human Retroviruses, 2004
• A θ‐defensin composed exclusively of d‐amino acids is active against HIV‐1
  Chemical Biology & Drug Design, 2004
• θ Defensins Protect Cells from Infection by Herpes Simplex Virus by Inhibiting Viral Adhesion and Entry
  Journal of Virology, 2004
• The θ-Defensin, Retrocyclin, Inhibits HIV-1 Entry
  AIDS Research and Human Retroviruses, 2003
• Evidence That the Transition of HIV-1 Gp41 into a Six-Helix Bundle, Not the Bundle Configuration, Induces Membrane Fusion
  The Journal of cell biology, 2000
• CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and Disease
  Annual Review of Immunology, 1999
• Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.
  Proceedings of the National Academy of Sciences, 1994
• A Synthetic Peptide from HIV-1 gp41 Is a Potent Inhibitor of Virus-Mediated Cell—Cell Fusion
  AIDS Research and Human Retroviruses, 1993
• The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain
  Cell, 1986